Persistent URL of this record https://hdl.handle.net/1887/103182
In Collections
This item can be found in the following collections:
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study
- All authors
- Younes, A.; Thieblemont, C.; Morschhauser, F.; Flinn, I.; Friedberg, J.W.; Amorim, S.; Hivert, B.; Westin, J.; Vermeulen, J.; Bandyopadhyay, N.; Vries, R. de; Balasubramanian, S.; Hellemans, P.; Smit, J.W.; Fourneau, N.; Oki, Y.
- Date
- 2014-08-31
- Journal
- The Lancet Oncology
- Volume
- 15
- Issue
- 9
- Pages
- 1019 - 1026